| scholarly article | Q13442814 |
| P50 | author | Jean-Marc Sabatier | Q56993871 |
| P2093 | author name string | Seyed Mahdi Kazemi | |
| P2860 | cites work | The Structure of the Potassium Channel: Molecular Basis of K + Conduction and Selectivity | Q22337058 |
| Mapping the receptor site for α-scorpion toxins on a Na + channel voltage sensor | Q24635953 | ||
| International Union of Pharmacology. LIV. Nomenclature and Molecular Relationships of Inwardly Rectifying Potassium Channels | Q24687431 | ||
| Scorpions from Mexico: From Species Diversity to Venom Complexity | Q26771795 | ||
| Scorpion toxins specific for potassium (K+) channels: a historical overview of peptide bioengineering | Q26853728 | ||
| Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasion | Q27004631 | ||
| The crystal structure of a voltage-gated sodium channel | Q27670752 | ||
| Chemical engineering and structural and pharmacological characterization of the α-scorpion toxin OD1 | Q27684283 | ||
| NMR sequential assignments and solution structure of chlorotoxin, a small scorpion toxin that blocks chloride channels | Q27730321 | ||
| Structure and regulation of voltage-gated Ca2+ channels | Q28141138 | ||
| Scorpion toxins specific for Na+-channels | Q28144635 | ||
| Therapeutic potential of venom peptides | Q28207222 | ||
| A hyaluronidase from Tityus serrulatus scorpion venom: isolation, characterization and inhibition by flavonoids | Q28209880 | ||
| Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci | Q28237061 | ||
| Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5 | Q28242922 | ||
| Structural analysis of a group III Glu62-phospholipase A2 from the scorpion, Mesobuthus tamulus: Targeting and reversible inhibition by native peptides | Q50548630 | ||
| The first potassium channel toxin from the venom of the Iranian scorpion Odonthobuthus doriae | Q50643321 | ||
| Potent modulation of the voltage-gated sodium channel Nav1.7 by OD1, a toxin from the scorpion Odonthobuthus doriae. | Q50650043 | ||
| Animal Toxins as Therapeutic Tools to Treat Neurodegenerative Diseases | Q51764192 | ||
| Solution structure of Lqh-8/6, a toxin-like peptide from a scorpion venom--structural heterogeneity induced by proline cis/trans isomerization. | Q52553480 | ||
| List of scorpions known in Egypt, Arabia, Israel, Libya, Syria, Jordan, Turkey, Iraq, Iran | Q54270934 | ||
| Cloning and molecular characterization of BumaMPs1, a novel metalloproteinases from the venom of scorpion Buthus martensi Karsch. | Q54762437 | ||
| A global accounting of medically significant scorpions: Epidemiology, major toxins, and comparative resources in harmless counterparts | Q57166301 | ||
| Sequential resonance assignment and secondary structure determination of the Ascaris trypsin inhibitor, a member of a novel class of proteinase inhibitors | Q57904903 | ||
| Venom-Derived Peptide Modulators of Cation-Selective Channels: Friend, Foe or Frenemy | Q63396036 | ||
| Purification and properties of phospholipase A2 from the venom of scorpion, (Heterometrus fulvipes) | Q67295481 | ||
| The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis | Q77670121 | ||
| [Trends in mortality from scorpion stings in Mexico, 1979-2003] | Q80968554 | ||
| Purification and properties of hyaluronidase from Palamneus gravimanus (Indian black scorpion) venom | Q81636359 | ||
| First Transcriptome Analysis of Iranian Scorpion, Mesobuthus Eupeus Venom Gland | Q90650797 | ||
| Expression of matrix metalloproteinase-2 and -9 in human ligamentum flavum cells treated with tumor necrosis factor-α and interleukin-1β. | Q38420558 | ||
| Treating autoimmune disorders with venom-derived peptides | Q38659535 | ||
| The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein | Q38726772 | ||
| Snake venom toxins: toxicity and medicinal applications | Q38849314 | ||
| Scorpion Toxin Polyptides as Therapeutic Agents: An Overview | Q38891630 | ||
| Medical application of scorpion venom to breast cancer: A mini-review | Q38958703 | ||
| The first report on transcriptome analysis of the venom gland of Iranian scorpion, Hemiscorpius lepturus | Q39200864 | ||
| Scorpion venom (Odontobuthus doriae) induces apoptosis by depolarization of mitochondria and reduces S-phase population in human breast cancer cells (MCF-7). | Q39468827 | ||
| Scorpion (Androctonus crassicauda) venom limits growth of transformed cells (SH-SY5Y and MCF-7) by cytotoxicity and cell cycle arrest | Q39549905 | ||
| Scorpion (Odontobuthus doriae) venom induces apoptosis and inhibits DNA synthesis in human neuroblastoma cells | Q39634232 | ||
| Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas | Q40197035 | ||
| Predicting scorpion sting incidence in an endemic region using climatological variables | Q40347201 | ||
| St20, a new venomous animal derived natural peptide with immunosuppressive and anti-inflammatory activities | Q40385297 | ||
| Hemilipin, a novel Hemiscorpius lepturus venom heterodimeric phospholipase A2, which inhibits angiogenesis in vitro and in vivo | Q40579005 | ||
| Hemicalcin, a new toxin from the Iranian scorpion Hemiscorpius lepturus which is active on ryanodine-sensitive Ca2+ channels | Q41989155 | ||
| Phaiodactylipin, a glycosylated heterodimeric phospholipase A from the venom of the scorpion Anuroctonus phaiodactylus. | Q42459763 | ||
| Hemitoxin, the first potassium channel toxin from the venom of the Iranian scorpion Hemiscorpius lepturus | Q42594510 | ||
| Molecular cloning of a novel putative potassium channel-blocking neurotoxin from the venom of the North African scorpion, Androctonus amoreuxi | Q42652472 | ||
| Antioxidant activity of hemocyanin; a pulse radiolysis study | Q43438549 | ||
| Molecular diversity of Chaerilidae venom peptides reveals the dynamic evolution of scorpion venom components from Buthidae to non-Buthidae | Q43839768 | ||
| Heteromtoxin (HmTx), a novel heterodimeric phospholipase A(2) from Heterometrus laoticus scorpion venom | Q43891966 | ||
| Epidemiological and clinical survey of scorpionism in Khuzestan province, Iran (2003). | Q44390972 | ||
| Critical amino acid residues determine the binding affinity and the Ca2+ release efficacy of maurocalcine in skeletal muscle cells | Q44517508 | ||
| OdK2, a Kv1.3 channel-selective toxin from the venom of the Iranian scorpion Odonthobuthus doriae. | Q44624444 | ||
| A thermoactive secreted phospholipase A₂ purified from the venom glands of Scorpio maurus: relation between the kinetic properties and the hemolytic activity | Q44645980 | ||
| Isolation of scorpion (Androctonus amoreuxi) putative alpha neurotoxins and parallel cloning of their respective cDNAs from a single sample of venom | Q46658999 | ||
| Cloning, sequence analysis and homology modeling of a novel phospholipase A2 from Heterometrus fulvipes (Indian black scorpion). | Q48079952 | ||
| Selective Voltage-Gated Sodium Channel Peptide Toxins from Animal Venom: Pharmacological Probes and Analgesic Drug Development. | Q48262154 | ||
| Voltage-Gated Calcium Channels | Q28242997 | ||
| Cytosolic phospholipase A2: biochemical properties and physiological roles | Q28244376 | ||
| Epidemiology of scorpionism: a global appraisal | Q28285127 | ||
| International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels | Q28289125 | ||
| International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels | Q28289168 | ||
| International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels | Q28289179 | ||
| International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels | Q28289202 | ||
| Innate immunity and the normal microflora | Q28373296 | ||
| Functional characterization of Kv channel beta-subunits from rat brain | Q28570222 | ||
| The expanding superfamily of phospholipase A(2) enzymes: classification and characterization | Q28609761 | ||
| Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release | Q28611028 | ||
| A new mid-Silurian aquatic scorpion-one step closer to land? | Q28650306 | ||
| Phylogenomic resolution of scorpions reveals multilevel discordance with morphological phylogenetic signal | Q28651363 | ||
| Odontobuthus tirgari sp. nov. (Scorpiones, Buthidae) from the eastern region of the Iranian Plateau | Q29466997 | ||
| Protein inhibitors of proteinases | Q29619496 | ||
| Serpins: structure, function and molecular evolution. | Q30333028 | ||
| The Concise Guide to PHARMACOLOGY 2015/16: Other ion channels | Q30488648 | ||
| Kalium: a database of potassium channel toxins from scorpion venom. | Q30489239 | ||
| Purification and primary structure of low molecular mass peptides from scorpion (Buthus sindicus) venom | Q30649104 | ||
| Phospholipin, a novel heterodimeric phospholipase A2 from Pandinus imperator scp6pion venom. | Q30810564 | ||
| Mining on scorpion venom biodiversity | Q30909390 | ||
| OD1, the first toxin isolated from the venom of the scorpion Odonthobuthus doriae active on voltage-gated Na+ channels | Q33220170 | ||
| Overview of scorpion toxins specific for Na+ channels and related peptides: biodiversity, structure-function relationships and evolution | Q33226757 | ||
| Transcriptome analysis of the venom gland of the Mexican scorpion Hadrurus gertschi (Arachnida: Scorpiones). | Q33284829 | ||
| Characterization of hadrucalcin, a peptide from Hadrurus gertschi scorpion venom with pharmacological activity on ryanodine receptors | Q33434136 | ||
| Scorpion fauna and epidemiological aspects of scorpionism in southeastern Iran | Q33629018 | ||
| The tale of a resting gland: transcriptome of a replete venom gland from the scorpion Hottentotta judaicus | Q33823266 | ||
| Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. | Q33925844 | ||
| Heminecrolysin, the first hemolytic dermonecrotic toxin purified from scorpion venom. | Q33928306 | ||
| Imperatoxin A, a Cell-Penetrating Peptide from Scorpion Venom, as a Probe of Ca-Release Channels/Ryanodine Receptors | Q34021802 | ||
| Peptides and genes coding for scorpion toxins that affect ion-channels. | Q34086633 | ||
| Molecular structure and physiological function of chloride channels | Q34120773 | ||
| An overview of toxins and genes from the venom of the Asian scorpion Buthus martensi Karsch | Q34148718 | ||
| Voltage-gated ion channels and gating modifier toxins. | Q34161355 | ||
| Electrophysiology and beyond: multiple roles of Na+ channel β subunits in development and disease | Q37769877 | ||
| Proteases as therapeutics | Q37853216 | ||
| Ion Channel Drug Discovery: Challenges And Future Directions | Q37998135 | ||
| Scorpion sting in Iran: A review | Q38023065 | ||
| Voltage-gated sodium channels: biophysics, pharmacology, and related channelopathies. | Q38026557 | ||
| Ryanodine receptors: structure and function. | Q38028455 | ||
| Structure and function of invertebrate Kunitz serine protease inhibitors | Q38062974 | ||
| K(+) channels: function-structural overview. | Q38110757 | ||
| Noncanonical roles of voltage-gated sodium channels | Q38153876 | ||
| Scorpion venom peptides with no disulfide bridges: a review | Q38159199 | ||
| Antimicrobial peptides from scorpion venoms | Q38222114 | ||
| Scorpion venom components as potential candidates for drug development | Q38272333 | ||
| Hg1, Novel Peptide Inhibitor Specific for Kv1.3 Channels from First Scorpion Kunitz-type Potassium Channel Toxin Family | Q34166046 | ||
| Epidemiological review of scorpion envenomation in iran | Q34256283 | ||
| Voltage-gated sodium channels at 60: structure, function and pathophysiology | Q34265707 | ||
| Novel Mammalian Group XII Secreted Phospholipase A2Lacking Enzymatic Activity, | Q34265835 | ||
| Structure and function of voltage-gated ion channels | Q34296742 | ||
| Current views on scorpion toxins specific for K+-channels | Q34328007 | ||
| Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors | Q34373019 | ||
| The mechanism of inhibition of ryanodine receptor channels by imperatoxin I, a heterodimeric protein from the scorpion Pandinus imperator | Q34422753 | ||
| Phylogenomic interrogation of arachnida reveals systemic conflicts in phylogenetic signal | Q34433014 | ||
| Ryanodine receptors of striated muscles: a complex channel capable of multiple interactions | Q34433539 | ||
| A spider-derived Kunitz-type serine protease inhibitor that acts as a plasmin inhibitor and an elastase inhibitor | Q34544946 | ||
| The poison Dart frog's batrachotoxin modulates Nav1.8. | Q34552425 | ||
| The phospholipase A2 superfamily and its group numbering system | Q34566140 | ||
| SjAPI, the First Functionally Characterized Ascaris-Type Protease Inhibitor from Animal Venoms | Q34637600 | ||
| Multiple actions of phi-LITX-Lw1a on ryanodine receptors reveal a functional link between scorpion DDH and ICK toxins | Q34720150 | ||
| CLC chloride channels: correlating structure with function | Q34774321 | ||
| Toxins Targeting the Kv1.3 Channel: Potential Immunomodulators for Autoimmune Diseases | Q35662935 | ||
| First venom gland transcriptomic analysis of Iranian yellow scorpion "Odonthubuthus doriae" with some new findings. | Q36079613 | ||
| Identification of the immunogenic epitopes of the whole venom component of the Hemiscorpius lepturus scorpion using the phage display peptide library. | Q36192403 | ||
| Covalent labeling of protein components of the sodium channel with a photoactivable derivative of scorpion toxin | Q36353987 | ||
| Sequence Characterization of cDNA Sequence of Encoding of an Antimicrobial Peptide With No Disulfide Bridge from the Iranian Mesobuthus Eupeus Venomous Glands | Q36660929 | ||
| Phospholipases and their industrial applications. | Q36707335 | ||
| Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). | Q36750162 | ||
| Cancer invasion and metastasis: changing views. | Q37038656 | ||
| Protease inhibitors from marine venomous animals and their counterparts in terrestrial venomous animals. | Q37040083 | ||
| K+ channel modulators for the treatment of neurological disorders and autoimmune diseases | Q37162392 | ||
| Animal toxins acting on voltage-gated potassium channels | Q37264924 | ||
| Two Biological Active Fractions Isolated from Buthotus schach (BS)Scorpion Venom Examined on Striated Muscle Preparation, In-vitro | Q37268219 | ||
| Phospholipase A2 structure/function, mechanism, and signaling | Q37326136 | ||
| Venom Components of Iranian Scorpion Hemiscorpius lepturus Inhibit the Growth and Replication of Human Immunodeficiency Virus 1 (HIV-1). | Q37358795 | ||
| Isolation and characterization of a high affinity peptide inhibitor of ClC-2 chloride channels | Q37377743 | ||
| Shellfish toxins targeting voltage-gated sodium channels | Q37424935 | ||
| Overview of scorpion species from China and their toxins | Q37670009 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 14 | |
| P921 | main subject | Arachnida | Q1358 |
| scorpion | Q19125 | ||
| drug discovery | Q1418791 | ||
| antineoplastic | Q2853144 | ||
| scorpion venom | Q75034359 | ||
| arthropod proteins | Q75832127 | ||
| antimicrobial cationic peptides | Q78188513 | ||
| P577 | publication date | 2019-07-23 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | Venoms of Iranian Scorpions (Arachnida, Scorpiones) and Their Potential for Drug Discovery | |
| P478 | volume | 24 |
Search more.